Form 4 for BHC Bausch Health Companies Inc.
Accepted 2024-07-17 00:00:00 ET · period of report 2024-07-15 · accession 0001127602-24-020566 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-17 | 2024-07-15 | BHC | Lenar Aimee J. | EVP, US Pharma | A - Grant | $0.00 | +144.4K | 144.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares, No Par Value | 2024-07-15 | A | A | 144,352 | $0.00 | 144,352 | D | — | — | (F1) Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. |